TG Therapeutics | TGTX - Pre Tax Profit

Stock Price
34.69
Daily Change
0.48 1.40%
Monthly
18.52%
Yearly
-3.59%
Q2 Forecast
32.52

TG Therapeutics reported $45.09M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 3.92B 2.35B Sep/2025
Ardelyx USD -400K 467K Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Curis USD 19.36M 33.34M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
J&J USD 4.97B 2.53B Dec/2025
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novavax USD 17.9M 220.94M Dec/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
Verastem USD -32.92M 944K Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025